Of the few studies that have investigated the importance and diagnostic value of novel tau fragments in plasma, an N-terminal fragment ending at Ser198 was found to distinguish healthy controls from AD-MCI and AD patients [51]. The gene discussed is MAPT; the disease is Alzheimer disease.